#1QWithCNBCTV18 | #AlkemLaboratories reports #Q1 earnings

- Net profit at ₹286.7 cr vs ₹127.6 cr (YoY)

- Revenue up 15.2% at ₹2,967.7 cr vs ₹2,576.3 cr (YoY)

- EBITDA up 91.6% at ₹389.1 cr vs ₹203.1 cr (YoY)

- EBITDA margin at 13.1% vs 7.8% (YoY) https://t.co/pSeMGe72O4

#1QWithCNBCTV18 | #AlkemLaboratories reports #Q1 earnings

- Other income at ₹65.8 cr vs ₹51.4 cr (YoY)

#AlkemLaboratories CFO says most of the observations issued by the #USFDA for the company's Baddi unit are procedural in nature